New treatments for peripheral artery disease

被引:1
|
作者
Bartholomew, John [1 ]
Bishop, G. Jay [1 ]
机构
[1] Cleveland Clin, Heart Vasc & Thorac Inst, Dept Cardiovasc Med, ST20,9500 Euclid Ave, Cleveland, OH 44195 USA
关键词
DUAL ANTIPLATELET THERAPY; CARDIOVASCULAR EVENTS; LOWER-EXTREMITY; TASK-FORCE; MANAGEMENT; ASPIRIN; INTERVENTIONS; CLOPIDOGREL; PREVENTION; VORAPAXAR;
D O I
10.3949/ccjm.87.s1.03
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The stenosis or occlusion of extremities defining peripheral artery disease (PAD) is a risk factor for adverse cardiovascular events and adverse limb events including amputation. PAD is common, can occur without symptoms or with claudication, and is easily diagnosed. Proper diagnosis and adherence to guideline-directed therapy can reduce the morbidity and potential mortality associated with PAD.
引用
收藏
页码:21 / 25
页数:5
相关论文
共 50 条
  • [41] The Role of Double and Triple Therapy with Direct Oral Anticoagulants in Coronary Artery Disease, Peripheral Artery Disease, and Stroke
    Romero, Natasha
    Lupi, Kenneth
    Carter, Danielle
    Malloy, Rhynn
    CLINICAL THERAPEUTICS, 2018, 40 (11) : 1907 - 1917
  • [42] Antithrombotic therapy in peripheral artery disease: A review of the EUCLID trial results and current ongoing trials
    Ward, Rachael
    Long, Chandler
    Patel, Manesh R.
    Jones, William S.
    CLINICAL CARDIOLOGY, 2018, 41 (01) : 137 - 143
  • [43] Antiplatelet therapy with or without anticoagulant therapy for lower extremity peripheral artery disease: A systematic review
    Rahmatian, Donna
    Barry, Arden R.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2021, 78 (23) : 2132 - 2141
  • [44] Rivaroxaban in peripheral artery disease: The new kid on the block?
    Hussain, Mohamad A.
    Verma, Subodh
    Al-Omran, Mohammed
    JOURNAL OF VASCULAR SURGERY, 2018, 67 (03) : 985 - 986
  • [45] DIABETIC FOOT & PERIPHERAL ARTERY DISEASE
    不详
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2020, 70 (11) : S52 - S55
  • [46] Antithrombotic therapy in peripheral artery disease
    Foley, T. Raymond
    Waldo, Stephen W.
    Armstrong, Ehrin J.
    VASCULAR MEDICINE, 2016, 21 (02) : 156 - 169
  • [47] The global pandemic of peripheral artery disease
    Hirsch, Alan T.
    Duval, Sue
    LANCET, 2013, 382 (9901) : 1312 - 1314
  • [48] Differences in responses of platelets to fluid shear stress in patients with peripheral artery disease (PAD) and coronary artery disease (CAD)
    Nambi, Vijay
    Kimball, Kay T.
    Bray, Paul F.
    Bergeron, Angela L.
    Johnson, Shawna L.
    Morrisett, Joel D.
    Chen, Changyi
    Lin, Peter H.
    Lumsden, Alan B.
    Ballantyne, Christie M.
    Dong, Jing-Fei
    PLATELETS, 2009, 20 (03) : 199 - 205
  • [49] Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization
    Hess, Connie N.
    Szarek, Michael
    Anand, Sonia S.
    Bauersachs, Rupert M.
    Patel, Manesh R.
    Debus, E. Sebastian
    Nehler, Mark R.
    Capell, Warren H.
    Beckman, Joshua A.
    Piazza, Gregory
    Henkin, Stanislav
    Bura-Riviere, Alessandra
    Lawall, Holger
    Roztocil, Karel
    Hsia, Judith
    Muehlhofer, Eva
    Berkowitz, Scott D.
    Haskell, Lloyd P.
    Bonaca, Marc P.
    JAMA NETWORK OPEN, 2022, 5 (06) : E2215580
  • [50] Ticagrelor in Peripheral Artery Disease Endovascular Revascularization (TI-PAD): Challenges in clinical trial execution
    Rogers, R. Kevin
    Hiatt, William R.
    Patel, Manesh R.
    Shishehbor, Mehdi H.
    White, Robin
    Khan, Naeem D.
    Bhalla, Narinder P.
    Jones, W. Schuyler
    Wang, Cecilia C. Low
    VASCULAR MEDICINE, 2018, 23 (06) : 513 - 522